News
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the most profitable biotech stocks to invest in now. TD Cowen analyst Tyler Van ...
Stryker Corporation (NYSE:SYK) is one of the top low volatility healthcare stocks to buy now. In a report released on July 20 ...
CNW/ - As Canada looks to encourage greater economic growth amid shifting economic and geopolitical forces, new research from TD reveals that many ...
Detailed price information for Kinsale Capital Group Inc (KNSL-N) from The Globe and Mail including charting and trades.
In a report released today, William Katz from TD Cowen reiterated a Buy rating on Invesco, with a price target of $29.00. The company’s shares opened today at $21.55. Take advantage of TipRanks ...
United Therapeutics Corporation (NASDAQ:UTHR) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 15, ...
CSX experienced a tough second quarter and first half of 2025, compared to the prior-year’s periods, but saw some sequential ...
TD Cowen has raised its price target for Strategy’s stock from $590 to $680 per share, citing the company’s deepening role as ...
Klaviyo, Inc. (NYSE:KVYO) is one of the Most Promising New Technology Stocks According to Wall Street Analysts. On June 23, ...
Pricing expectations stalled in second-quarter 2025 and remain below our rail shipper survey’s long-term average. Business ...
TD Cowen defends Strategy Inc.'s Bitcoin premium, calling criticism “logically flawed.” Strategy continues buying BTC, boosting holdings and investor returns.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results